These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 21240465)
1. CIAPIN1 confers multidrug resistance through up-regulation of MDR-1 and Bcl-L in LoVo/Adr cells and is independent of p53. Zhang YF; Li XH; Shi YQ; Wu YY; Li N; He Q; Ji Q; Wang RQ; Yang SM; Fang DC Oncol Rep; 2011 Apr; 25(4):1091-8. PubMed ID: 21240465 [TBL] [Abstract][Full Text] [Related]
2. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532 [TBL] [Abstract][Full Text] [Related]
3. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825 [TBL] [Abstract][Full Text] [Related]
4. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells. Wang G; Rong J; Zhou Z; Duo J Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809 [TBL] [Abstract][Full Text] [Related]
5. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
6. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Hao Z; Li X; Qiao T; Du R; Hong L; Fan D Cancer Biol Ther; 2006 Mar; 5(3):261-6. PubMed ID: 16410721 [TBL] [Abstract][Full Text] [Related]
7. [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA]. Li X; Fan R; Zou X; Hong L; Gao L; Jin H; Du R; He L; Xia L; Fan D Mol Biol (Mosk); 2008; 42(1):102-9. PubMed ID: 18389626 [TBL] [Abstract][Full Text] [Related]
8. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer. Guo L; Zhou Y; Sun Y; Zhang F Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564 [TBL] [Abstract][Full Text] [Related]
9. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Sui H; Zhou S; Wang Y; Liu X; Zhou L; Yin P; Fan Z; Li Q Carcinogenesis; 2011 May; 32(5):667-75. PubMed ID: 21296766 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation. Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858 [TBL] [Abstract][Full Text] [Related]
11. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells. Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756 [TBL] [Abstract][Full Text] [Related]
12. [Relationship between multidrug resistance in human colon carcinoma LoVo/Adr cell line and intracellular calcium ion concentration]. Ma Q; Zhang ZS; Zhang YL; Lai ZS Ai Zheng; 2002 Aug; 21(8):846-9. PubMed ID: 12478890 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp. He Q; Zhang G; Hou D; Leng A; Xu M; Peng J; Liu T Oncol Rep; 2011 Jan; 25(1):237-43. PubMed ID: 21109982 [TBL] [Abstract][Full Text] [Related]
14. The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells. Kong D; Ma S; Liang B; Yi H; Zhao Y; Xin R; Cui L; Jia L; Liu X; Liu X Biomed Pharmacother; 2012 Jun; 66(4):271-8. PubMed ID: 22564245 [TBL] [Abstract][Full Text] [Related]
15. MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells. Zhang X; Wu X; Li J; Sun Y; Gao P; Zhang C; Zhang H; Zhou G J Surg Oncol; 2011 Oct; 104(5):466-71. PubMed ID: 21538359 [TBL] [Abstract][Full Text] [Related]
16. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145 [TBL] [Abstract][Full Text] [Related]
17. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Radetzki S; Köhne CH; von Haefen C; Gillissen B; Sturm I; Dörken B; Daniel PT Oncogene; 2002 Jan; 21(2):227-38. PubMed ID: 11803466 [TBL] [Abstract][Full Text] [Related]
19. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Li J; Chen Y; Zhao J; Kong F; Zhang Y Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697 [TBL] [Abstract][Full Text] [Related]
20. Increased resistance to anticancer therapy of mouse cells lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein. Wurzer G; Herceg Z; Wesierska-Gadek J Cancer Res; 2000 Aug; 60(15):4238-44. PubMed ID: 10945636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]